Skip to main content

Company News

  • October 14, 2025

    bioMérieux invests in Allergen Alert, a startup resulting from its intrapreneurship program

    bioMérieux has just acquired a stake in Allergen Alert, an innovative startup specializing in the rapid detection of food allergens for individuals and professionals.
  • September 29, 2025

    bioMérieux publishes a Bioethics Charter: A first in the diagnostics sector

    bioMérieux confirms its ethical commitment to clinical research through a Bioethics Charter that guarantees transparency, accountability, and respect for human dignity. In particular, it aims to protect research participants when collecting and using biological samples and personal data.
  • July 23, 2025

    bioMérieux and Moderna Collaborate to Advance individualized Cancer Therapies

    bioMérieux has a long history of collaboration with Moderna, a biotechnology company that gained worldwide recognition during the COVID-19 pandemic for its rapid development of a mRNA-based vaccine. Today, this partnership is helping accelerate the development of individualized cancer treatments.
  • April 17, 2025

    bioMérieux Embarks its Customers in a Circular Economy Initiative

    BIOLOOP™ is an innovative project to recycle plastic Petri dishes from infectious waste into new reagents packaging—reducing CO₂ emissions and supporting a circular economy in healthcare.
  • April 10, 2025

    bioMérieux partners with Mila to harness artificial intelligence for diagnostics 

    This partnership aims to develop innovative solutions to improve the accuracy and efficiency of in vitro diagnostic tools and detection of antibiotic resistance.